Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and or Biodegradable Spacer: a Prospective Randomized Clinical Trial.

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options. The study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 85
Healthy Volunteers: f
View:

• Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification.

• Persistent pain for at least 3 months, with documented failure of conservative treatment

• Age ranging from 60 years of age to 85 years of age

Locations
Other Locations
Norway
Hospital of Southern Norway, Arendal
RECRUITING
Arendal
Oslo university hospital
NOT_YET_RECRUITING
Oslo
Contact Information
Primary
Hannah Ugletveit Jahr, Cand. med.
hannah.jahr@gmail.com
+47 90762377
Backup
Berte Bøe, PhD
uxbebm@ous-hf.no
+47 41338451
Time Frame
Start Date: 2020-11-01
Estimated Completion Date: 2029-09-01
Participants
Target number of participants: 50
Treatments
Experimental: Group A: Biodegradable spacer
Intervention group
Active_comparator: Group B: control group
Control group
Related Therapeutic Areas
Sponsors
Leads: Oslo University Hospital

This content was sourced from clinicaltrials.gov